Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yurong Lai

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|April 19, 2012
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug developmentYurong Lai, Manthena Varma, Bo Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2016
Disrupted Murine Gut-to-Human Liver Signaling Alters Bile Acid Homeostasis in Humanized Mouse Liver ModelsEdwin C Y Chow, Holly P Quach, Yueping Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte dataHannah M Jones, Hugh A Barton, Yurong Lai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 24, 2015
Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular ExpressionHong Shen, Tongtong Liu, Bridget L Morse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 28, 2011
Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytesEmi Kimoto, Robert Walsky, Hui Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2012
In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigationYi-An Bi, Emi Kimoto, Samantha Sevidal, et al.
Clinical Pharmacology and Therapeutics|January 24, 2019
Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted ProteomicsSarah Billington, Laurent Salphati, Cornelis E C A Hop, et al.
Drug Metabolism Letters|October 22, 2013
Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogsJohn Scott Daniels, Yurong Lai, Sarah South, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4Michael J Hafey, Lauren M Aleksunes, Christy C Bridges, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 31, 2015
Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In VitroYueping Zhang, Yong-Hae Han, Siva Prasad Putluru, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Expert Opinion on Drug Metabolism & Toxicology|April 19, 2012
Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug developmentYurong Lai, Manthena Varma, Bo Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2016
Disrupted Murine Gut-to-Human Liver Signaling Alters Bile Acid Homeostasis in Humanized Mouse Liver ModelsEdwin C Y Chow, Holly P Quach, Yueping Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte dataHannah M Jones, Hugh A Barton, Yurong Lai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 24, 2015
Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular ExpressionHong Shen, Tongtong Liu, Bridget L Morse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 28, 2011
Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytesEmi Kimoto, Robert Walsky, Hui Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2012
In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigationYi-An Bi, Emi Kimoto, Samantha Sevidal, et al.
Clinical Pharmacology and Therapeutics|January 24, 2019
Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted ProteomicsSarah Billington, Laurent Salphati, Cornelis E C A Hop, et al.
Drug Metabolism Letters|October 22, 2013
Inhibition of hepatobiliary transporters by a novel kinase inhibitor contributes to hepatotoxicity in beagle dogsJohn Scott Daniels, Yurong Lai, Sarah South, et al.
Clinical Pharmacology and Therapeutics|May 13, 2022
Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4Michael J Hafey, Lauren M Aleksunes, Christy C Bridges, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 31, 2015
Diclofenac and Its Acyl Glucuronide: Determination of In Vivo Exposure in Human Subjects and Characterization as Human Drug Transporter Substrates In VitroYueping Zhang, Yong-Hae Han, Siva Prasad Putluru, et al.
Pageof 14